PsychedelicNewsBreaks

ThursdayOct 18, 2018 10:57 am

PsychedelicNewsBreaks – Earth Science Tech, Inc. (ETST) to Begin Formulating New Full Spectrum CBD Beverage Utilizing Immune-Boosting Patent

Biotechnology company Earth Science Tech, Inc. (OTCQB: ETST) today announced that it will begin formulating a new full spectrum CBD beverage that will leverage its University of Central Oklahoma Provisional Patent, which is designed to improve immune system functions. “The CBD beverage is a most in the époque of legalization of recreative marijuana. Not only does CBD have positive effects on immune cells, it has strong antioxidant and anti-psychotic properties,” Michel Aube, CEO and CSO of ETST, stated in the news release. “Indeed, it is now well recognized that CBD is an anti-psychotic molecule and that CBD has opposite effect…

Continue Reading

TuesdayOct 02, 2018 10:47 am

PsychedelicNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Issues Response to DEA Rescheduling of CBD

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), a premium functional food and beverage company, this morning issued a response to the U.S. Drug Enforcement Administration’s recent decision to remove cannabis component cannabidiol from its Schedule I list of controlled substances. “We see this reclassification of CBD in pharmaceuticals as a good sign that will bolster the growing awareness of CBD as a substance that delivers many benefits, and opens the door for other CBD-based treatments, in line with the recent FDA approval of a drug to treat childhood epilepsy,” Jim Bailey, president and CEO of Phivida, stated in the news…

Continue Reading

WednesdaySep 19, 2018 12:43 pm

PsychedelicNewsBreaks – Sugarmade, Inc. (SGMD) Strategic Investment Offers Great Opportunity in the Cannabis Sector

Hydroponic supply company Sugarmade (OTC: SGMD) earlier this month reported that it will be investing an estimated $1 million in capital in Hempistry, Inc. A recent article further discussing the company’s investment reads: “One of the primary reasons that the Hempistry project is such an attractive entry point for Sugarmade is the hemp grown by the company, which contains high levels of CBD while containing low levels (less than 0.3 percent) of THC. Both are natural compounds found in cannabis, but they create vastly different effects when consumed. CBD is a non-psychoactive compound that doesn’t produce the problematic ‘high’ associated…

Continue Reading

TuesdaySep 18, 2018 12:49 pm

PsychedelicNewsBreaks – The Coca-Cola Co. (NYSE: KO) Evaluates Opportunity in the Evolving Cannabis Market

Coca-Cola (NYSE: KO) is the latest beverage company assessing its options in the ever-evolving cannabis market and is presently in talks with Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF), according to BNN Bloomberg. A recent article by Jen Skerritt and Craig Giammona on Bloomberg.com titled, “Coca-Cola Is Eyeing the Cannabis Market” highlights the company’s potential decision to join the growing ranks of mainstream businesses investing in the cannabis sector. Per the article, Coca-Cola is particularly interested in drinks infused with non-psychoactive cannabinoid (“CBD”). “We are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around…

Continue Reading

TuesdaySep 11, 2018 3:20 pm

PsychedelicNewsBreaks – Why Sugarmade, Inc. (SGMD) is “One to Watch”

Hydroponic supply company Sugarmade (OTC: SGMD) is a product and brand marketing company investing in products and brands with disruptive potential. A recent article further discussing the company reads: “Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich…

Continue Reading

FridayJul 20, 2018 10:19 am

PsychedelicNewsBreaks – Marijuana Company of America Inc. (MCOA) Subsidiary Targets Cosmetics Sector with Botanical Moisturizer

Marijuana Company of America (OTC: MCOA), through its hempSMART™ brand, recently announced the rollout of its latest cannabidiol-derived cosmetic product for people seeking an all-natural botanical moisturizer. An article further discussing the product reads: “The hempSMART™ Face product marks Marijuana Company of America’s expansion of its hempSMART™ brand into the cosmetic products space, building on a portfolio of legal CBD-based wellness innovations.  The company states that each bottle of its hempSMART™ Face (http://cnw.fm/nS7Qd) contains 150 mg of full-spectrum, non-psychoactive cannabidiol (CBD) oil derived from the industrial hemp plant. The new topical nourishes facial skin with ayurvedic herbs and botanicals that…

Continue Reading

FridayJul 13, 2018 11:40 am

PsychedelicNewsBreaks – Marijuana Company of America Inc. (MCOA) Improves Patent Pending hempSMART Brain Product Formulation

Marijuana Company of America (OTC: MCOA) functions as an umbrella company supporting an assortment of portfolio businesses operating in the legal cannabis and hemp industry. In June, the company announced that its hempSMART™ brand relaunched its flagship patent pending product, hempSMART™ Brain. An article further discussing the product reads: “The improved formulation includes 300mg per bottle of full spectrum, non-psychoactive, water soluble CBD (10mg per serving), along with a botanical blend of all-natural plant-based ingredients. To learn more about the hempSMART™ Brain product, read the full press release (http://cnw.fm/2dKSp). The brand offers a line of CBD products and the opportunity…

Continue Reading

WednesdayJun 20, 2018 1:40 pm

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Continues to Develop Potential Uses of Patented Technology

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and is already licensing DehydraTECH™, a technology that improves the bio-absorption and bioavailability of ingestible substances. A recent article discussing the company’s unique technology reads: “Application of the technology extends beyond nicotine to non-psychoactive cannabinoids, vitamins and non-steroidal anti-inflammatory drugs (NSAIDs), and Lexaria has licensed the technology to a number of companies, including chocolate maker Nuka Enterprises; cannabis beverage manufacturer GP Holdings; and Biolog, which markets hemp-based, cannabidiol (CBD)-infused products and vitamins. Lexaria is expected to sign 6-12 more licensing agreements in 2018. These are typically six-figure contracts in the first…

Continue Reading

TuesdayJun 19, 2018 10:39 am

PsychedelicNewsBreaks – Marijuana Company of America Inc.’s (MCOA) hempSMART Brand Launches New CBD-Infused Moisturizer

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced that the company’s hempSMART™ brand has launched its groundbreaking new cosmetic product, hempSMART™ Face. The newly developed topical product is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (“CBD”) oil derived from the industrial hemp plant. hempSMART™ Face is a facial moisturizer designed to refresh, replenish, and restore skin cells using a combination of CBD oil and a unique blend of ayurvedic herbs and botanicals. “Our team is excited to announce the expansion of the hempSMART™ brand into the world of cosmetic products. HempSMART™ will continue…

Continue Reading

FridayJun 15, 2018 3:09 pm

PsychedelicNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Positioned in Growing Markets with Novel Therapies and Groundbreaking Delivery Platform

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is positioned in rapidly-growing markets with innovative preventative therapies and a groundbreaking cannabidiol (“CBD”) drug delivery platform. An article discussing this reads, “Research has shown CBD to be non-psychoactive and to have anti-inflammatory, anti-anxiety and anti-emetic properties (http://cnw.fm/o5xXH). Following nasal administration, the formulations gel rapidly with mucosal tissue to facilitate direct nose-to-brain delivery of cannabinoids. The gel substantially improves bioavailability and provides controlled cannabinoid release, staying in the nasal passages for up to seven days.” To view the full article, visit http://cnw.fm/X4Koh About PreveCeutical Medical Inc. PreveCeutical is a health sciences…

Continue Reading